Study reveals new insight into susceptibility to pneumonia

May 3, 2017 by David Stacey, University of Western Australia
Study reveals new insight into susceptibility to pneumonia
Credit: University of Western Australia

A new research study of immune responses to pneumococcal vaccines, commonly given to people with compromised immune systems, young children and people over 65, has identified a type of immune cell which is important in generating antibodies that prevent people from developing pneumococcal pneumonia.

In the study conducted by researchers at The University of Western Australia, people with (HIV) infection, including those successfully treated with antiretroviral therapy, and people not infected by HIV were given a pneumococcal vaccine and various immune cells and their function examined in blood before and after vaccination.

The researchers found in those without HIV infection, production of antibodies was strongly associated with a type of immune cell, called T-follicular helper cells, which are critical for generating .

In contrast, people with HIV infection produced far fewer of these cells, which was related to lower antibody responses and, importantly, these abnormalities persisted in people with treated HIV infection.

The study, published today in PLOS ONE was carried out by Dr Laila Abudulai under the supervision of Dr Sonia Fernandez and Professor Martyn French from UWA's Faculty of Health and Medical Sciences.

Dr Abudulai said that it was the first time that T-follicular helper cells had been shown to be important in the production of antibodies to pneumococcal vaccines.

"Our findings may lead to the development of new ways to assess the effectiveness of such vaccines," she said.

Professor French said that the discoveries provided new information about why people with HIV infection were much more susceptible to pneumococcal pneumonia than those without HIV infection.

"Pneumococcal vaccines are very effective in preventing pneumonia but are less effective in people with compromised immune systems, particularly HIV-infected people," he said.

"The findings presented in this paper shed important light on the mechanisms of antibody production after pneumococcal vaccination and how this is adversely affected by HIV infection."

Identification of blood immune cells that could be used as a biomarker to assess the efficacy of will be beneficial to not only HIV-infected people but also other with an increased susceptibility to pneumococcal pneumonia.

Explore further: Super-vaccine to guard against all strains of pneumococcal disease

More information: Laila N. Abudulai et al. Production of IgG antibodies to pneumococcal polysaccharides is associated with expansion of ICOS+ circulating memory T follicular-helper cells which is impaired by HIV infection, PLOS ONE (2017). DOI: 10.1371/journal.pone.0176641

Related Stories

Super-vaccine to guard against all strains of pneumococcal disease

August 17, 2016
A new super-vaccine with the ability to eliminate all 90 known strains of the world's most deadly bacterial disease is being developed.

Researchers find key mechanism to control antibody production

April 28, 2017
A research team from iMM Lisboa led by Luís Graça has found a cellular mechanism that underlies the development of autoimmune diseases.

Newly identified antibodies may improve pneumonia vaccine design

September 22, 2011
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how a novel type of antibody works against pneumococcal bacteria. The findings, which could improve vaccines against pneumonia, appear ...

Seniors need two pneumonia vaccines, CDC advisory panel says

February 3, 2015
(HealthDay)—Adults 65 and older need two vaccines to better protect them from bacterial infection in the blood (called sepsis), meningitis and pneumonia, according to a revised vaccination schedule from the 2015 Advisory ...

Team uses Google analytical tool to gauge vaccine effectiveness

February 1, 2017
Using a statistical method initially developed by Google, a Yale School of Public Health-led research team has devised a novel way to better analyze the impact of vaccines. The research was published in the Proceedings of ...

RSV infection may be associated with higher risk for bacterial pneumonia

January 6, 2015
Two common and sometimes dangerous respiratory diseases, a viral one caused by respiratory syncytial virus (RSV), and a bacterial one caused by Streptococcus pneumoniae may be linked, suggests a study published in this week's ...

Recommended for you

Ambitious global virome project could mark end of pandemic era

February 23, 2018
Rather than wait for viruses like Ebola, SARS and Zika to become outbreaks that force the world to react, a new global initiative seeks to proactively identify, prepare for and stop viral threats before they become pandemics.

Forecasting antibiotic resistance with a 'weather map' of local data

February 23, 2018
The resistance that infectious microbes have to antibiotics makes it difficult for physicians to confidently select the right drug to treat an infection. And that resistance is dynamic: It changes from year to year and varies ...

A synthetic approach to helping the immune system thwart infections

February 22, 2018
Yale researchers have developed a set of synthetic molecules that may help boost the strength of a key, virus-fighting protein.

Scientists find molecular link between Vitamin A derivative and mouse intestinal health

February 22, 2018
New research shows that all-trans-retinoic acid (atRA), the active form of vitamin A, regulates immune system responses in the mouse intestine by controlling expression of the protein HIC1 in cells known as innate lymphoid ...

Scientists gain new insight on how antibodies interact with widespread respiratory virus

February 22, 2018
Scientists have found and characterized the activity of four antibodies produced by the human immune system that target an important protein found in respiratory syncytial virus (RSV), according to new research published ...

Study reveals how kidney disease happens

February 22, 2018
Monash researchers have solved a mystery, revealing how certain immune cells work together to instigate autoimmune kidney disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.